Phase III ADVANCE: 96-Wk Primary Efficacy Analysis of DTG + FTC/(TAF or TDF) vs EFV/FTC/TDF in ART-Naive PWH in South Africa

Clinical Care Options (CCO) expert analysis of new data from CROI 2021, provided by expert HIV faculty

Joseph J. Eron, Jr., MD
Program Director Princy N. Kumar, MD, FIDSA, MACP
Program Director Eric S. Daar, MD Renslow Sherer, MD Released: May 10, 2021

HIV PrEP Strategies

Pregnancy, Postpartum Period, and Children/Adolescents

Current and Investigational ART

Coinfections

CCO commentary by Dr. Darcy Wooten on data presented at CROI 2021 regarding integrase strand inhibitor-associated weight gain and clinical implications

Darcy Wooten, MD Released: May 5, 2021

Download free expert-authored slides to see how clinicians use HIV-ASSIST to choose appropriate, guideline-based antiretroviral therapy

Jehan Budak, MD Ethel D. Weld, MD, PhD Released: April 26, 2021

Free expert slides from Clinical Care Options (CCO) reviewing the use of HIV-ASSIST for ART and LTBI treatment selection in a patient with HIV

Nicky Mehtani, MD, MPH Released: April 26, 2021